FDA
approval
· 2023-10-30
FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application for citalopram hydrobromide from Aurobindo Pharma Limited.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM (CITALOPRAM HYDROBROMIDE)